Explore more Norwegian companies →

COMPANY CARD COMPANY

ALGIPHARMA AS

Business reg. no. 964 911 444ASBÆRUMIndustry code 72.100

Research and experimental development on natural sciences and engineering

Equity ratio: Good · 84,8 % (2025)
Company financial statements in NOK · 2023: 85 940 NOK · 2024: 5 738 NOK · 2025: 29 219 NOK
2023–2025 · NOK
Operating revenue29 219 NOK
2025 · company↑ 409,2 % from 2024
Company financial statements in NOK · 2023: -5 843 676 NOK · 2024: -6 858 426 NOK · 2025: -6 725 210 NOK
2023–2025 · NOK
Operating income · EBIT-6,7 million NOK
2025 · company↑ 133 216 NOK from 2024

-23 016,6 % EBIT margin

Registered employees5 employees
RegisteredRegistry data 19.11.2026

FINANCIALS

Financial statements and key figures

Amount in whole currency units
Company financial statements

Amount in NOK

Company financial statements · amounts without rounding to thousands for display
Financial statement item20252024202320222021
CurrencyNOKNOKNOKNOKNOK
Operating revenue29 2195 73885 94040,00065,000
Operating profit-6 725 210-6 858 426-5 843 676-7,945,000-6,637,000
Net income-8 676 949-8 962 504-9 715 740-7,073,000-10,658,000
Equity197 468 543176 145 487128 587 96127,888,00034,962,000
Total assets232 824 118207 325 830188 878 585173,351,000155,526,000
Total liabilities35 355 57431 180 34360 290 624145,462,000120,565,000
EBIT margin-23 016,6 %-119 526,4 %-6 799,7 %-19 862,5 %-10 210,8 %

Historical company accounts in NOK. The source identifies the year. A dash indicates an unavailable amount.

Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.

Show trend in NOK
Operating revenueNOK · 2023–202529 219 NOK
↑ 409,2 % from 2024
Operating revenue202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Operating profitNOK · 2023–2025-6,7 million NOK
↑ 133 216 NOK from 2024
Operating profit202320242025

Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.

Sources and conversion basis

Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.

  • 2025 · NOK · original-NOK · source version 54f716b32e69
  • 2024 · NOK · original-NOK · source version 3faf31100829
  • 2023 · NOK · original-NOK · source version 817dcc96f9da

Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.

Income statement14 entries with information
Company financial statements · Income statement · whole currency units
Financial statement item20252024202320222021
Operating revenue
Total sales revenue29 2195 73885 94040,00065,000
Total operating revenue29 2195 73885 94040,00065,000
Operating expenses
Wage costs1 185 141-230 253-561 0562,237,0002,561,000
Total operating expenses6 754 4296 864 1635 929 616——
Operating profit
Operating income (EBIT)-6 725 210-6 858 426-5 843 676-7,945,000-6,637,000
Financial income
Total finance income1 603 1441 714 4831 868 7802,223,00079,000
Financial expenses
Other interest expense1 257 233982 9181 651 8381,070,000970,000
Interest expense to company in same group928 7662 360 1023 551 576——
Total finance costs3 554 8833 818 5615 856 6141,352,0004,099,000
Net finance result-1 951 739-2 104 079-3 987 833——
Results and tax
Income before tax-8 676 949-8 962 504-9 831 509-7,073,000-10,658,000
Tax expense on ordinary income00-115 769——
Net income-8 676 949-8 962 504-9 715 740-7,073,000-10,658,000
Total comprehensive income-8 676 949-8 962 504-9 715 740——
Balance sheet12 entries with information
Company financial statements · Balance sheet · whole currency units
Financial statement item20252024202320222021
Intangible assets
Goodwill00———
Financial fixed assets
Total non-current assets225 097 166201 536 517181 567 841168,449,000149,488,000
Current assets
Total receivables6 046 9484 617 7736 326 2104,037,0005,073,000
Total cash and cash equivalents1 680 0041 171 540984 533865,000965,000
Total current assets7 726 9525 789 3137 310 7444,902,0006,038,000
Total assets232 824 118207 325 830188 878 585173,351,000155,526,000
Equity
Total paid-in equity197 468 543176 145 487128 587 96127,888,00034,962,000
Total equity197 468 543176 145 487128 587 96127,888,00034,962,000
Provisions and long-term liabilities
Total long-term liabilities20 184 64914 823 88847 665 861——
Current liabilities
Total current liabilities15 170 92516 356 45512 624 76317,695,0008,305,000
Total liabilities35 355 57431 180 34360 290 624145,462,000120,565,000
Total
Total equity and liabilities232 824 118207 325 830188 878 585173,351,000155,526,000
Executive salaryUnavailable

No information in the available financial statement data.

Some amounts for 2021 and 2022 come from a financial statements archive and are rounded to the nearest NOK 1,000. The source does not specify reporting dates or whether these figures cover the company or a group.

REGISTRY INFORMATION

Company at a glance

Registered
Industry
72.100 · Research and experimental development on natural sciences and engineering Industry classification: Statistics Norway · CC BY 4.0
Registered address
Industriveien 33, 1337 SANDVIKA
Founded
25.05.1992
Entity type
Main entity

ADDRESS AND PROPERTY

Property information

Open data

Industriveien 33, 1337 SANDVIKA

Loading property information …

© Kartverket · CC BY 4.0

Companies at the same address

Available company cards

    About the address match

    Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.

    REGISTERED ROLES

    The people and companies behind it.

    Search registered roles →Explore positions and documented connections.
    NameRoleSource date
    Yngvar Peter BergBorn 1962Board member14.11.2026
    Yngvar Peter BergBorn 1962General manager14.11.2026
    Diderik Børsting SchnitlerBorn 1946Board member14.11.2026
    CEDRA NORGE ASView role recordAuditor14.11.2026
    Arne DessenBorn 1959Chair of the board14.11.2026

    Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.

    YEAR-DATED OWNERSHIP

    Reported shareholders.

    Search shareholders →Find a shareholder and follow reported ownership entries.

    As of 31 December 2025 · 1 of 1 available ownership entries

    ShareholderShare / share classSource date
    ALGIPHARMA HOLDING ASView ownership entryView share entries →100,00 % · Ordinary shares31.12.2025
    Distribution of share count 31.12.2025
    100,0 %displayed share of shares
    • ALGIPHARMA HOLDING ASOrdinary shares100,00 %

    Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.

    Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.

    Previously reported ownership entries (2)

    YEAR-DATED OWNERSHIP

    Company share entries

    The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.

    YEAR-DATED OWNERSHIP

    Indirect ownership

    Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.

    Source and scope

    Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.

    Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.

    CONNECTIONS

    Explore the ownership structure.

    Directly reported ownership entries are shown first. Open the map to explore further.

    Direct ownership entries without an interactive map

    As of 31 December 2025 · 1 of 1 available ownership entries

    ShareholderShare / share classSource date
    ALGIPHARMA HOLDING ASView ownership entryView share entries →100,00 % · Ordinary shares31.12.2025

    Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.

    Open interactive map for direct ownership entries

    CONNECTIONS

    Explore the ownership structure.

    See owners and open further company levels, using the same year throughout the tree.

    Year-end ownership